pharma news today obesity drugs glp-1 october 2025 Agonists Market Report 2025-2033, By Product, Molecule, and Geo Alarming rise in weight loss

Is microdosing semaglutide or tirzepatide safe

When safety oversight gaps + online marketing + supply shortages collide, patients pay the price

Learn what the diet industry doesnt want you to know: how to lose weight and keep it off

Note: Trulicity is administered once a week, on the same day each week

Glucagon-like peptide-1 receptor agonist (GLP-1 RA) drug use appears to be associated with increased residual gastric content (RGC) detected by gastric ultrasonography, a major risk factor for aspiration

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are peptide-derived analogs that were initially investigated to treat type 2 diabetes